BridgeBio Pharma, Inc. (BBIO): 2 insider purchases in the last two years; 8 trades disclosed by members of Congress.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 30, 2025 | Valantine Hannah Director | 2,338 | $12.84 | $30.0K | no history |
| Jun 30, 2025 | Valantine Hannah Director | 1,752 | $14.24 | $24.9K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.
| Filed | Member | Type | Amount |
|---|---|---|---|
| Oct 12, 2026 | Gilbert Cisneros | partial sale | $1,001 - $15,000 |
| Jun 8, 2026 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| May 8, 2026 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| Apr 7, 2026 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| Apr 7, 2026 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| Apr 7, 2026 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| Oct 10, 2025 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| Sep 12, 2025 | Gilbert Cisneros | purchase | $1,001 - $15,000 |